Under the agreement, Broadlane clients will have access to Integra products for the management of hydrocephalus, backed by Integra sales support. Broadlane clients include more than 1,100 acute-care hospitals and 50,000 non-acute care facilities across the United States.
Read the Integra LifeSciences release about the contract with The Broadlane Group.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences to Feature Total Wrist Fusion System for Arthritis Treatment
– Integra LifeSciences Receives FDA Clearance for ALIF Device
– Integra LifeSciences Introduces New Retraction System for Minimally Invasive Spine Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
